America's Children: Key National Indicators of Well-Being, 2011
Immunization
Data on vaccination coverage are used to identify groups at risk of vaccine-preventable diseases, to monitor vaccination coverage, and to evaluate the effectiveness of programs designed to increase coverage. Rates of childhood and adolescent immunizations are one measure of how extensively children are protected from serious vaccine-preventable illnesses.
Indicator HC3.A: Percentage of children ages 19–35 months with the 4:3:1:3:3:1 combined series of vaccinations by poverty status, 2002–2009
NOTE: The 4:3:1:3:3:1 series consists of 4 doses (or more) of diphtheria, tetanus toxoids, and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids, and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; 3 doses (or more) of hepatitis B vaccines; and 1 dose (or more) of varicella vaccine. The collection of coverage estimates for this series began in 2002. The recommended immunization schedule for children is available at http://www.cdc.gov/vaccines/recs/schedules/child-schedule.htm#printable. The 2009 series estimates were affected by the Hib vaccine shortage and the interim Advisory Committee on Immunization Practices (ACIP) recommendation to suspend the booster dose for healthy children from December 2007 to June 2009, a time when most children in the 2009 National Immunization Survey would have been eligible for the booster dose of the Hib vaccine.
SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey.
Indicator HC3.B: Percentage of adolescents ages 13–17 with the routinely recommended-for-age vaccinations, 2006–2009
NOTE: Data collection for 2006 and 2007 only included the fourth quarter. Human papillomavirus (HPV) coverage level indicates females initating the 3-dose series. Routinely recommended vaccines for administration beginning at ages 11–12 include tetanus-diphtheria-acellular pertussis (Tdap) and meningococcal conjugate (MenACWY) vaccines (both one dose), and HPV vaccine (3 doses) for females only. The recommended immunization schedule for adolescents is available at http://198.246.98.21/vaccines/recs/schedules/child-schedule.htm#printable.
SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey Teen.
- In 2009, 70 percent of children ages 19–35 months had received the recommended combined six-vaccine series. The 2009 estimate was affected by the Hib vaccine shortage and the related interim ACIP recommendation.48
- Children living in families with incomes below the poverty level had lower rates of coverage (68 percent) compared with children in families with incomes at or above the poverty level (70 percent).
- Adolescent vaccination coverage has increased steadily since 2006, when data were first collected. Vaccination coverage with 1 dose (or more) of the Tdap increased from 30 percent in 2007 to 56 percent in 2009, and coverage with 1 dose (or more) of the MenACWY increased from 32 percent in 2007 to 54 percent in 2009.
- The percentage of adolescent females initiating the HPV series with 1 dose (or more) increased from 25 percent in 2007 to 44 percent in 2009.
HC3.A HTML Table, HC3.B HTML Table
48 The 2009 series estimates were affected by the Hib vaccine shortage and the interim Advisory Committee on Immunization Practices (ACIP) recommendation to suspend the booster dose for healthy children from December 2007 to June 2009, a time when most children in the 2009 National Immunization Survey would have been eligible for the booster dose of the Hib vaccine.